Last update 24 Mar 2025

Nerinetide

Overview

Basic Info

Drug Type
Recombinant polypeptide
Synonyms
Nerinetide (USAN/INN), FN-023, FN023
+ [2]
Target
Action
inhibitors
Mechanism
PSD95 inhibitors(Disks large homolog 4 inhibitors)
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
D11729--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Ischemic StrokePhase 3
United States
01 Mar 2017
Acute Ischemic StrokePhase 3
Australia
01 Mar 2017
Acute Ischemic StrokePhase 3
Canada
01 Mar 2017
Acute Ischemic StrokePhase 3
Germany
01 Mar 2017
Acute Ischemic StrokePhase 3
Ireland
01 Mar 2017
Acute Ischemic StrokePhase 3
South Korea
01 Mar 2017
Acute Ischemic StrokePhase 3
Sweden
01 Mar 2017
Acute Ischemic StrokePhase 3
United Kingdom
01 Mar 2017
Brain IschemiaPhase 3
Canada
26 Mar 2015
Aneurysm, RupturedPhase 2
United States
01 Nov 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
71
stnqhsajqk(ftcinrmmul) = rqcaoezkoo cdwgixiqbl (utpcqioeeb, 5.9 - 28.1)
-
01 Feb 2022
Placebo
stnqhsajqk(ftcinrmmul) = afbyypdpcw cdwgixiqbl (utpcqioeeb, 3.1 - 27.0)
Phase 3
1,105
Placebo
owfgqcgxqo = hxmtbjwnrt ebqxvunavh (wgxlcgfwje, elbkryhfmu - rrbcjsvops)
-
14 Dec 2020
Phase 3
1,105
qukipwiltu(tibuknpbuq) = Serious adverse events occurred equally between groups. byhrocwnen (ixnfxhjzwp )
Negative
14 Mar 2020
Placebo
Phase 2
185
(1 NA-1)
ofiwqsascg(evlanhrzxl) = xwucjvxjtx emvihxixwn (pcjfbyulxw, 5598)
-
17 Oct 2013
placebo
(2 Placebo)
ofiwqsascg(evlanhrzxl) = qmjtpavbyi emvihxixwn (pcjfbyulxw, 1611)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free